|
|
Vaccine Detail
|
Intracel KLH Vaccine |
| Vaccine Information |
- Vaccine Name: Intracel KLH Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: Subunit vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Antigen: Keyhole Limpet Hemocyanin (KLH) (NCT00000105)
- Immunization Route: subcutaneous injection
- Description: This vaccine could teach T-cells to detect and kill cancer cells better. Intracel KLH is given without adjuvant subcutaneously and with Tetanus Toxoid 0.5 ml intramuscularly. (NCT00000105)
|
| Host Response |
|
|
| References |
NCT00000105: Vaccination With Tetanus and KLH to Assess Immune Responses [https://clinicaltrials.gov/study/NCT00000105]
|
|
